← Back to Clinical Trials
Recruiting NCT06375681

NCT06375681 Effectiveness of Cognitive Training in Older and Younger Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06375681
Status Recruiting
Phase
Sponsor University of Wisconsin, Madison
Condition Cognitive Change
Study Type INTERVENTIONAL
Enrollment 1,600 participants
Start Date 2025-04-01
Primary Completion 2027-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
Visual and / or Auditory Cognitive Tasks (1)Visual and / or Auditory Cognitive Tasks (2)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,600 participants in total. It began in 2025-04-01 with a primary completion date of 2027-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The proposed study will enroll 1600 participants to examine the effectiveness of cognitive training. Participants will be randomized into different experimental groups and can expect to participate for up to 15 hours of research over 4 to 8 weeks.

Eligibility Criteria

Inclusion Criteria: * Self-reported normal or corrected-to-normal vision * No known neurological impairments * Age within inclusion range (18-30 Years for Younger Adults and 60-85 Years for Older Adults) Exclusion Criteria * Physical handicap (motor or perceptual) that would impede training procedures * Concurrent enrollment in other cognitive training studies * Not being proficient enough in English that would prevent following and understanding all instructions and completing all testing sessions (typically, participants would need to have learned English before age 11; there might be some exceptions that will be decided on a case-by-case basis). * Unable to adhere to training schedule Additional exclusion criteria for older adults: \- Score \< 17 (out of 22) on the Telephone Montreal Cognitive Assessment (T-MoCA).

Contact & Investigator

Central Contact

C. Shawn Green, PhD

✉ cshawn.green@wisc.edu

📞 (608) 263-4868

Principal Investigator

Aaron R. Seitz, PhD

PRINCIPAL INVESTIGATOR

University of California, Riverside

Frequently Asked Questions

Who can join the NCT06375681 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Cognitive Change. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06375681 currently recruiting?

Yes, NCT06375681 is actively recruiting participants. Contact the research team at cshawn.green@wisc.edu for enrollment information.

Where is the NCT06375681 trial being conducted?

This trial is being conducted at Riverside, United States, Boston, United States, Madison, United States.

Who is sponsoring the NCT06375681 clinical trial?

NCT06375681 is sponsored by University of Wisconsin, Madison. The principal investigator is Aaron R. Seitz, PhD at University of California, Riverside. The trial plans to enroll 1,600 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology